Search Results - "Howles, C.M."

Randomized, controlled, open-label, non-inferiority study of the CONSORT algorithm for individualized dosing of follitropin alfa by Olivennes, F, Trew, G, Borini, A, Broekmans, F, Arriagada, P, Warne, D.W, Howles, C.M

“…Abstract In this randomized, controlled, open-label, phase IV study, ovarian response after a follitropin alfa starting dose determined by the CONSORT…”
Get full text

Health outcomes of children born after IVF/ICSI: a review of current expert opinion and literature by Fauser, B.C.J.M, Devroey, P, Diedrich, K, Balaban, B, Bonduelle, M, Delemarre-van de Waal, H.A, Estella, C, Ezcurra, D, Geraedts, J.P.M, Howles, C.M, Lerner-Geva, L, Serna, J, Wells, D

“…Abstract The Sixth Evian Annual Reproduction (EVAR) Workshop Group Meeting was held to evaluate the impact of IVF/intracytoplasmic sperm injection on the…”
Get full text

Identification of ovarian response predictors for a newly available recombinant FSH preparation by Howles, C.M, Jenkins, J, Griesinger, G, Warne, D.W

Get full text

Factors related to successful ovulation induction in patients with WHO group II anovulatory infertility by Howles, C.M, Alam, V, Tredway, D, Homburg, R, Warne, D.W

“…Abstract To identify baseline characteristics related to successful ovulation induction, data were analysed from oligo- or anovulatory patients undergoing…”
Get full text

Comparison of the efficacy and tolerability of two formulations of vaginal progesterone for luteal phase support in frozen embryo transfer cycles by Lan, V.T.N, Tuan, P, Canh, L, Tuong, H, Howles, C.M

Get full text

Contemporary genetic technologies and female reproduction by Fauser, B C J M, Diedrich, K, Bouchard, P, Domínguez, F, Matzuk, M, Franks, S, Hamamah, S, Simón, C, Devroey, P, Ezcurra, D, Howles, C M

“…BACKGROUND The Fifth Evian Annual Reproduction (EVAR) Workshop Meeting discussed knowledge regarding contemporary genetics in female reproduction. METHODS…”
Get full text

Cell-specific expression of aromatase and LH receptor mRNAs in rat ovary by Whitelaw, P F, Smyth, C D, Howles, C M, Hillier, S G

“…Current understanding of the endocrine and paracrine regulation of follicular oestrogen synthesis predicts that aromatase cytochrome P450 (P450arom) mRNA is…”
Get more information

Effects of recombinant LH treatment on folliculogenesis and responsiveness to FSH stimulation by Durnerin, Cedrin I., Erb, K., Fleming, R., Hillier, H., Hillier, S.G., Howles, C.M., Hugues, J.-N., Lass, A., Lyall, H., Rasmussen, P., Thong, J., Traynor, I., Westergaard, L., Yates, R.

“…BACKGROUND The role of LH in sensitizing antral follicles to FSH is unclear. LH is required for normal hormone production and normal oocyte and embryo…”
Get full text

A double-blind, randomized study to compare recombinant human follicle stimulating hormone (FSH; Gonal-F®) with highly purified urinary FSH (Metrodin® HP) in women undergoing assisted reproductive techniques including intracytoplasmic sperm injection by Frydman, R., Howles, C.M., Truong, F.

“…This prospective, double-blind, randomized, multicentre study compared the efficacy and safety of recombinant human follicle stimulating hormone (r-hFSH;…”
Get full text

Contemporary genetic technologies and female reproduction by Fauser, B.C.J.M., Diedrich, K., Bouchard, P., Domínguez, F., Matzuk, M., Franks, S., Hamamah, S., Simón, C., Devroey, P., Ezcurra, D., Howles, C.M.

Get full text

The use of a decremental dose regimen in patients treated with a chronic low-dose step-up protocol for WHO Group II anovulation: a prospective randomized multicentre study by Hugues, J.N., Cédrin-Durnerin, I., Howles, C.M.

“…BACKGROUND: In women with chronic anovulation, the choice of the FSH starting dose and the modality of subsequent dose adjustments are critical in controlling…”
Get full text

A prospective, randomized comparison of two starting doses of recombinant FSH in combination with cetrorelix in women undergoing ovarian stimulation for IVF/ICSI by Wikland, M., Bergh, C., Borg, K., Hillensjö, T., Howles, C.M., Knutsson, A., Nilsson, L., Wood, M.

“…BACKGROUND: A prospective randomized study was carried out in two centres to compare the number of oocytes retrieved after two different starting doses of…”
Get full text

Cost-effectiveness modelling of recombinant FSH versus urinary FSH in assisted reproduction techniques in the UK by Daya, S., Ledger, W., Auray, J.P., Duru, G., Silverberg, K., Wikland, M., Bouzayen, R., Howles, C.M., Beresniak, A.

“…BACKGROUND: The purpose of this study was to undertake an economic evaluation to compare the cost-effectiveness of recombinant (r)FSH with urinary (u)FSH for…”
Get full text

Does growth hormone-releasing factor assist follicular development in poor responder patients undergoing ovarian stimulation for in-vitro fertilization? by Howles, C.M., Loumaye, E., Germond, M., Yates, R., Brinsden, P., Healy, D., Bonaventura, L.M., Strowitzki, T.

“…Treatment with growth hormone-releasing factor (GRF) has been reported to improve the ovarian response to gonadotrophins in women who respond poorly to ovarian…”
Get full text

Multiple follicular development and ovarian steroidogenesis following subcutaneous administration of a highly purified urinary FSH preparation in pituitary desensitized women undergoing IVF: a multicentre European phase III study by Howles, C M, Loumaye, E, Giroud, D, Luyet, G

“…A multicentre, multinational study was carried out between November 1990 and February 1992 to assess the safety and efficacy of a new highly purified urinary…”
Get more information

A comparative prospective study of a chronic low dose versus a conventional ovulation stimulation regimen using recombinant human follicle stimulating hormone in anovulatory infertile women by Hedon, B, Hugues, J N, Emperaire, J C, Chabaud, J J, Barbereau, D, Boujenah, A, Howles, C M, Truong, F

“…The efficacy and safety of a chronic low dose (group A) and a conventional (group B) stimulation regimen of recombinant human follicle stimulating hormone…”
Get full text

P-211. A comparative prospective study of a chronic low-dose versus a conventional ovulation stimulation regimen using recombinant human FSH (Gonal-F®) in WHO group II anovulatory infertile women by Hedon, B., Hugues, J.N., Emperaire, J.C., Chabaud, J.J., Barbereau, D., Boujenah, A., Howles, C.M., Truong, F.

Get full text

O-109. Recombinant human FSH (Gonal-F®) versus highly purified urinary FSH (Metrodin HP®): results of a randomized comparative study in women undergoing assisted reproductive techniques by Berg, C., Howles, C.M., Borg, K., Hamberger, L., Josefsson, B., Nilsson, L., Wikland, M.

Get full text

Follicular development and early luteal function of conception and non-conceptional cycles after human in-vitro fertilization: endocrine correlates by Howles, C M, Macnamee, M C, Edwards, R G

“…Two-hundred patients, half of whom had on-going pregnancies, were examined in terms of follicular growth, urinary oestrogen and LH output, oocytes recovered…”
Get more information

Effect of luteinizing hormone on follicle stimulating hormone-activated paracrine signalling in rat ovary by Smyth, C D, Miró, F, Howles, C M, Hillier, S G

“…'Pure' follicle stimulating hormone (FSH) and luteinizing hormone (LH) are expected shortly to become available for pharmaceutical use in the clinical setting…”
Get more information